Clinical Trial Update: Preliminary Study of Pharmacokinetics of Ginkgolides Meglumine Injection. [Phase 4]

View source ↗

Summary

Phase 4 pharmacokinetic study of Ginkgolides Meglumine Injection in patients with ischemic stroke.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Ginkgolides Meglumine Injection (ginkgolide meglumine)

Snippet

Sponsor: Jiangsu Kanion Pharmaceutical Co., Ltd | Conditions: Ischemic Stroke | Phase 4 | Status: COMPLETED